Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16689)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2014 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Eshraghian A, Jahromi AH. Non-alcoholic fatty liver disease and thyroid dysfunction: A systematic review. World J Gastroenterol 2014; 20(25): 8102-8109 [PMID: 25009382 DOI: 10.3748/wjg.v20.i25.8102] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i25/8102.htm |
| Number | Citing Articles |
| 1 |
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United European Gastroenterology Journal 2018; 6(1): 97 doi: 10.1177/2050640617707863
|
| 2 |
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. Journal of Clinical and Experimental Hepatology 2020; 10(1): 81 doi: 10.1016/j.jceh.2019.07.008
|
| 3 |
N. Dauth, A. Vermehren, J. Bojunga. Hormonstörungen bei Lebererkrankungen. Der Gastroenterologe 2017; 12(6): 453 doi: 10.1007/s11377-017-0203-z
|
| 4 |
Hyun Jin Kim. Importance of thyroid-stimulating hormone levels in liver disease. Journal of Pediatric Endocrinology and Metabolism 2020; 33(9): 1133 doi: 10.1515/jpem-2020-0031
|
| 5 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Complicaciones extrahepáticas de la enfermedad por hígado graso no alcohólico: impacto más allá del hígado. Revista de Gastroenterología de México 2019; 84(4): 472 doi: 10.1016/j.rgmx.2019.05.004
|
| 6 |
Ahmed Salman, Mohamed Aon, Amr Hussein, Mohamed Salman, Mohamed Tourky, Ahmed Mahmoud, Feras Aljarad, Mohamed Elkaseer, Hossam El-Din Shaaban, Ahmed Moustafa, Ahmed El-Mikkawy, Nahla Gaballa, Heba Abdallah, Zaky Ftouh Zaky Rashed, Hesham Elkassar. Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. International Journal of General Medicine 2021; : 5711 doi: 10.2147/IJGM.S326315
|
| 7 |
Bruno Halpern. Elevated irisin and alanine aminotransferase levels in hypothyroidism: role of oxidative stress?. Archives of Endocrinology and Metabolism 2016; 60(2): 89 doi: 10.1590/2359-3997000000166
|
| 8 |
|
| 9 |
Sabu Augustine, R. Harshitha, Ramesh Sangayya Hiremath, H. Anil Kumar, K. C. Prajwal. Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital. Cureus 2023; doi: 10.7759/cureus.37094
|
| 10 |
Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1057769
|
| 11 |
Alba Martínez Escudé, Guillem Pera, Ingrid Arteaga, Carmen Expósito, Lluís Rodríguez, Pere Torán, Llorenç Caballeria. Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. Medicina Clínica (English Edition) 2020; 154(1): 1 doi: 10.1016/j.medcle.2019.03.025
|
| 12 |
Weiwei He, Xiaofei An, Ling Li, Xiaoqing Shao, Qian Li, Qiuming Yao, Jin-an Zhang. Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00335
|
| 13 |
Mst. Noorjahan Begum, Suprovath Kumar Sarker, Golam Sarower Bhuyan, Md Tarikul Islam, Shahinur Haque, Tasnia Kawsar Konika, Syeda Kashfi Qadri, Tasnuva Ahmed, Hurjahan Banu, Nusrat Sultana, Asifuzaman Rahat, Kohinoor Jahan Shyamaly, Suraiya Begum, Sadia Sultana, Sheikh Maksudur Rahman, Narayan Saha, Taufiqur Rahman Bhuiyan, Mohiul Islam Chowdhury, Mizanul Hasan, M. A. Hasanat, Abu A. Sajib, Abul B.M.M.K Islam, Sharif Akhteruzzaman, Syed Saleheen Qadri, Firdausi Qadri, Kaiissar Mannoor. Profiling of Carnitine and Acylcarnitines of Late-Diagnosed Hypothyroid Patients with Fatigue Under Levothyroxine Treatment. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3995419
|
| 14 |
Eleonore Fröhlich, Richard Wahl. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease. Metabolites 2022; 12(8): 718 doi: 10.3390/metabo12080718
|
| 15 |
Hong Fan, Lili Li, Zhenqiu Liu, Liou Cao, Xingdong Chen, Chen Suo, Tiejun Zhang. The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. Digestive and Liver Disease 2023; 55(6): 785 doi: 10.1016/j.dld.2022.11.020
|
| 16 |
Renfei Wang, Jian Tan, Guizhi Zhang, Wei Zheng, Chengxia Li. Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of 131iodine treatment. Medicine 2017; 96(5): e6035 doi: 10.1097/MD.0000000000006035
|
| 17 |
Pegah Golabi, Haley Bush, Zobair M. Younossi. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2017; 21(4): 739 doi: 10.1016/j.cld.2017.06.010
|
| 18 |
Sarah Elshinshawy, Hemmat Elhaddad, Shereen Abdel Alem, Olfat Shaker, Randa Salam, Ayman Yosry, Ibrahim Elebrashy. The Interrelation Between Hypothyroidism and Non-alcoholic Fatty Liver Disease, a Cross-sectional Study. Journal of Clinical and Experimental Hepatology 2023; 13(4): 638 doi: 10.1016/j.jceh.2023.03.004
|
| 19 |
Maria Mavromati, François R. Jornayvaz. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. International Journal of Molecular Sciences 2021; 22(23): 12797 doi: 10.3390/ijms222312797
|
| 20 |
Eugenia R. Gatiatulina, Elizaveta V. Popova, Valentina S. Polyakova, Anastasia A. Skalnaya, Eduard F. Agletdinov, Alexandr A. Nikonorov, Anatoly V. Skalny, Alexey A. Tinkov. Evaluation of tissue metal and trace element content in a rat model of non-alcoholic fatty liver disease using ICP-DRC-MS. Journal of Trace Elements in Medicine and Biology 2017; 39: 91 doi: 10.1016/j.jtemb.2016.08.007
|
| 21 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Extrahepatic complications of non-alcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(4): 472 doi: 10.1016/j.rgmxen.2019.05.004
|
| 22 |
Huan-Xin Liu, Yan-Yan Ren, Cui-Qiao Meng, Zhong Li, Qian Nie, Chun-Hong Yu, Hui-Juan Ma. Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.961803
|
| 23 |
Renyi Xiao, Chunjue Ni, Yefeng Cai, Yili Zhou, Xiaohua Gong, Keyue Xie, Jie You. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma. Endocrine 2023; 80(3): 619 doi: 10.1007/s12020-023-03312-y
|
| 24 |
Julia Zuarth-Vázquez, Lidia Moreno-Castañeda, Juan Pablo Soriano-Márquez, Alain Velázquez-Alemán, Martha Helena Ramos-Ostos, Misael Uribe, Iván López-Méndez, Eva Juárez-Hernández. Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease. Life 2023; 13(4): 1048 doi: 10.3390/life13041048
|
| 25 |
Simonetta Lugari, Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo. Hypothyroidism and nonalcoholic fatty liver disease – a chance association?. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0047
|
| 26 |
Mohammad Hossein Dabbaghmanesh, Farideh Danafar, Ahad Eshraghian, Gholamhossein Ranjbar Omrani. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(4): 513 doi: 10.1016/j.dsx.2018.03.006
|
| 27 |
Ruheena Yasmeen, Humera Hafsa Jabeen, Raafia Aseena, Kaunain Taneem, Umer Syed. An Observational Study to Determine Severity and Complications Associated with Non-Alcoholic Fatty Liver Disease with Special Emphasis on Riskfactors. Research Journal of Pharmacy and Technology 2021; : 5498 doi: 10.52711/0974-360X.2021.00959
|
| 28 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Direct effects of thyroid hormones on hepatic lipid metabolism. Nature Reviews Endocrinology 2018; 14(5): 259 doi: 10.1038/nrendo.2018.10
|
| 29 |
Luigi Marino, Adam Kim, Bin Ni, Francesco S. Celi. Thyroid hormone action and liver disease, a complex interplay. Hepatology 2023; doi: 10.1097/HEP.0000000000000551
|
| 30 |
Roberta D'Ambrosio, Irene Campi, Marco Maggioni, Riccardo Perbellini, Enza Giammona, Roberta Stucchi, Marta Borghi, Elisabetta Degasperi, Annalisa De Silvestri, Luca Persani, Laura Fugazzola, Pietro Lampertico, Pavel Strnad. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLOS ONE 2021; 16(4): e0249614 doi: 10.1371/journal.pone.0249614
|
| 31 |
T. E.‐M. Kaltenbach, T. Graeter, S. Oeztuerk, D. Holzner, W. Kratzer, M. Wabitsch, C. Denzer. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents. Pediatric Obesity 2017; 12(1): 67 doi: 10.1111/ijpo.12110
|
| 32 |
Lukas Denkmayr, Alexandra Feldman, Lars Stechemesser, Sebastian Eder, Stephan Zandanell, Michael Schranz, Michael Strasser, Ursula Huber-Schönauer, Stephan Buch, Jochen Hampe, Bernhard Paulweber, Carolin Lackner, Heike Haufe, Karl Sotlar, Christian Datz, Elmar Aigner. Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. Journal of Clinical Medicine 2018; 7(12): 562 doi: 10.3390/jcm7120562
|
| 33 |
Ahad Eshraghian. Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(42): 7495-7504 doi: 10.3748/wjg.v23.i42.7495
|
| 34 |
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
|
| 35 |
Limei Li, Yan Song, Yongquan Shi, Liangliang Sun. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. The Journal of Clinical Endocrinology & Metabolism 2023; 108(7): 1602 doi: 10.1210/clinem/dgad072
|
| 36 |
Ernest Yorke. Co-Morbid Hypothyroidism and Liver Dysfunction: A Review. Clinical Medicine Insights: Endocrinology and Diabetes 2024; 17 doi: 10.1177/11795514241231533
|
| 37 |
Tzu-Chieh Hung, Nengjiang Zhao, Caoxin Huang, Suhuan Liu, Tao Liu, Wenfang Huang, Xiangbin Xu, Zhi-Liang Ji, Shuyu Yang. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation. Biomedicine & Pharmacotherapy 2021; 138: 111408 doi: 10.1016/j.biopha.2021.111408
|
| 38 |
Şule Demir, Mustafa Ünübol, Serap Ünübol Aypak, Emrah İpek, Serdar Aktaş, Gamze Sevri Ekren, Murat Yılmaz, Recai Tunca, Engin Güney. Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats. International Journal of Endocrinology 2016; 2016: 1 doi: 10.1155/2016/5083746
|
| 39 |
Anaïs Vallet-Pichard, Lucia Parlati, Stanislas Pol. Épidémiologie de la stéato-hépatite non alcoolique. Étendue du problème et son impact sur la santé publique. La Presse Médicale 2019; 48(12): 1459 doi: 10.1016/j.lpm.2019.08.008
|
| 40 |
Shouchun Xiao, Jingna Cui, Aisong Chen, Haonan Hou, Jianing Yao, Yue Cao, Yaofeng Fang, Xueke Liu, Zhiqiang Zhou, Donghui Liu, Peng Wang. Thyroid Dysfunction Induced by Fungicide Famoxadone Exposure Contributes to Nonalcoholic Fatty Liver Disease in Male Mice: In Vivo, In Vitro, and In Silico Studies. Environmental Science & Technology 2023; 57(40): 14881 doi: 10.1021/acs.est.3c04419
|
| 41 |
Wei Jiang, Chang-hai Liu, Dongbo Wu, You-Juan Wang, Hong Tang. Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan. Bioscience Reports 2021; 41(12) doi: 10.1042/BSR20211769
|
| 42 |
Fabio Gionfra, Paolo De Vito, Valentina Pallottini, Hung-Yun Lin, Paul J. Davis, Jens Z. Pedersen, Sandra Incerpi. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00532
|
| 43 |
Sanjay Kalra, Sameer Aggarwal, Deepak Khandelwal, Pawel Grzmil. Thyroid Dysfunction and Dysmetabolic Syndrome: The Need for Enhanced Thyrovigilance Strategies. International Journal of Endocrinology 2021; 2021: 1 doi: 10.1155/2021/9641846
|
| 44 |
Rafael Aguiar Marschner, Fernanda Arenhardt, Rafael Teixeira Ribeiro, Simone Magagnin Wajner. Influence of Altered Thyroid Hormone Mechanisms in the Progression of Metabolic Dysfunction Associated with Fatty Liver Disease (MAFLD): A Systematic Review. Metabolites 2022; 12(8): 675 doi: 10.3390/metabo12080675
|
| 45 |
Tomislav Kizivat, Ivana Maric, Dunja Mudri, Ines Bilic Curcic, Dragan Primorac, Martina Smolic. Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00027
|
| 46 |
Grazia Pennisi, Ciro Celsa, Federica Spatola, Marcello Dallio, Alessandro Federico, Salvatore Petta. Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. International Journal of Environmental Research and Public Health 2019; 16(22): 4334 doi: 10.3390/ijerph16224334
|
| 47 |
Liang Liu, Ping Li, Yuqiang Mi, Yonggang Liu, Yiqi Liu, Peng Zhang. Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B. Medicine 2019; 98(46): e17945 doi: 10.1097/MD.0000000000017945
|
| 48 |
Qin Feng, Susan S. Baker, Wensheng Liu, Ricardo A. Arbizu, Ghanim Aljomah, Maan Khatib, Colleen A. Nugent, Robert D. Baker, Trudy M. Forte, Yiyang Hu, Lixin Zhu. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers. Pathology 2015; 47(4): 341 doi: 10.1097/PAT.0000000000000251
|
| 49 |
Areti Sofogianni, Athanasios Filippidis, Lampros Chrysavgis, Konstantinos Tziomalos, Evangelos Cholongitas. Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. World Journal of Hepatology 2020; 12(8): 493-505 doi: 10.4254/wjh.v12.i8.493
|
| 50 |
Marijana Jandrić-Kočič. Role of hypothyroidism in the onset of metabolic syndrome and hepatic steatosis. Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 2019; 24(75): 47 doi: 10.5937/medgla1975048J
|
| 51 |
Lisa B. VanWagner, Mary E. Rinella. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2): 75 doi: 10.1007/s11901-016-0295-9
|
| 52 |
Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. International Journal of Environmental Research and Public Health 2019; 16(18): 3415 doi: 10.3390/ijerph16183415
|
| 53 |
Fateme Ziamanesh, Mehdi Mohammadi, Sholeh Ebrahimpour, Ozra Tabatabaei-Malazy, Asieh Mosallanejad, Bagher Larijani. Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review. Journal of Diabetes & Metabolic Disorders 2023; 22(2): 1083 doi: 10.1007/s40200-023-01293-3
|
| 54 |
Alba Martínez Escudé, Guillem Pera, Ingrid Arteaga, Carmen Expósito, Lluís Rodríguez, Pere Torán, Llorenç Caballeria. Relación entre el hipotiroidismo y el hígado graso no alcohólico en una población española. Medicina Clínica 2020; 154(1): 1 doi: 10.1016/j.medcli.2019.03.018
|
| 55 |
Kristina R. Chacko, John Reinus. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2016; 20(2): 387 doi: 10.1016/j.cld.2015.10.004
|
| 56 |
Matina Kouvari, Laura Valenzuela‐Vallejo, Evangelos Axarloglou, Ornella Verrastro, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S. Mantzoros. Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study. Liver International 2024; 44(3): 848 doi: 10.1111/liv.15847
|
| 57 |
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim. Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(2): 221 doi: 10.3350/cmh.2020.0239
|
| 58 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Reciprocal Crosstalk Between Autophagic and Endocrine Signaling in Metabolic Homeostasis. Endocrine Reviews 2017; 38(1): 69 doi: 10.1210/er.2016-1103
|
| 59 |
Irina Kube, Holger Jastrow, Dagmar Führer, Denise Zwanziger. Thyroid Hormone Deficiency Modifies Hepatic Lipid Droplet Morphology and Molecular Properties in Lithogenic-Diet Supplemented Mice. Experimental and Clinical Endocrinology & Diabetes 2021; 129(12): 926 doi: 10.1055/a-1404-7939
|
| 60 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2020; : 1 doi: 10.1007/978-3-319-66362-3_6-1
|
| 61 |
P. Manka, J.D. Coombes, R. Boosman, K. Gauthier, S. Papa, W.K. Syn. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Letters 2018; 419: 175 doi: 10.1016/j.canlet.2018.01.055
|
| 62 |
Nicholas Scalzo, Mehtap Canastar, Edward Lebovics. Part 1: Disease of the Heart and Liver. Cardiology in Review 2022; 30(3): 111 doi: 10.1097/CRD.0000000000000379
|
| 63 |
Kailash Chandra, Johar Iqbal. Protein carbonylation in freshly diagnosed hypothyroidism is independent of thyrotropin levels. LaboratoriumsMedizin 2018; 42(5): 177 doi: 10.1515/labmed-2018-0052
|
| 64 |
Sanjay Neeralagi, Praveen N., Anil Kumar, Chethan T. L., Geetha Geetha, Sathish R.. Study of Thyroid Function in Alcoholic Liver Cirrhosis and Its Correlation with Child Pugh Score. Journal of Evidence Based Medicine and Healthcare 2020; 7(13): 689 doi: 10.18410/jebmh/2020/150
|
| 65 |
Tolga Sahin, Alihan Oral, Fatih Turker, Erdem Kocak. Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?. Medicine 2020; 99(11): e19492 doi: 10.1097/MD.0000000000019492
|
| 66 |
Claudia Mandato, Ida D’Acunzo, Pietro Vajro. Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What’s new. Digestive and Liver Disease 2018; 50(11): 1163 doi: 10.1016/j.dld.2018.08.026
|
| 67 |
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology 2018; 11: 175628481881150 doi: 10.1177/1756284818811508
|
| 68 |
Kazuki Tahara, Takemi Akahane, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Yuuki Tsuji, Daisuke Kaya, Hiroyuki Ogawa, Hirotetsu Takagi, Koji Ishida, Akira Mitoro, Hitoshi Yoshiji. Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease. JGH Open 2020; 4(3): 400 doi: 10.1002/jgh3.12264
|
| 69 |
Fatih Türker, Tolga Sahın, Alihan Oral, Erdem Koçak, Betül Çavuşoğlu Türker, Adil Niğdelioğlu, Hayriye Esra Ataoğlu Ataoğlu. Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis. International Journal of General Medicine 2022; : 859 doi: 10.2147/IJGM.S339474
|
| 70 |
Matthias Pinter, Lukas Haupt, Florian Hucke, Simona Bota, Theresa Bucsics, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart, Sheng-Nan Lu. The impact of thyroid hormones on patients with hepatocellular carcinoma. PLOS ONE 2017; 12(8): e0181878 doi: 10.1371/journal.pone.0181878
|
| 71 |
Hong Fan, Lili Li, Zhenqiu Liu, Pengyan Zhang, Sheng Wu, Xinyu Han, Xingdong Chen, Chen Suo, Liou Cao, Tiejun Zhang. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-022-02612-3
|
| 72 |
Eline H. van den Berg, Lynnda J.N. van Tienhoven-Wind, Marzyeh Amini, Tim C.M.A. Schreuder, Klaas Nico Faber, Hans Blokzijl, Robin P.F. Dullaart. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. Metabolism 2017; 67: 62 doi: 10.1016/j.metabol.2016.11.002
|
| 73 |
Narges Ashraf Ganjooei, Tannaz Jamialahmadi, Mohsen Nematy, Najeeb Zaheer Shah, Sara Jangjoo, Nima Emami, Ali Jangjoo, Reyhaneh Faridnia, Mona Alidadi, Thozhukat Sathyapalan, Amirhossein Sahebkar. Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery. Middle East Journal of Digestive Diseases 2022; 14(4): 410 doi: 10.34172/mejdd.2022.302
|
| 74 |
Lynnda van Tienhoven-Wind, Robin Dullaart. Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers. Nutrients 2015; 7(2): 1352 doi: 10.3390/nu7021352
|
| 75 |
Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan, Branka Filipović. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6678142
|
| 76 |
Valeria Calcaterra, Irene Degrassi, Silvia Taranto, Cecilia Porro, Alice Bianchi, Sara L’assainato, Giustino Simone Silvestro, Antonia Quatrale, Gianvincenzo Zuccotti. Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?. Children 2024; 11(2): 244 doi: 10.3390/children11020244
|
| 77 |
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
|
| 78 |
Fatma Yahyaoğlu Gökmen, Süleyman Ahbab, Hayriye Esra Ataoğlu, Betül Çavuşoğlu Türker, Faik Çetin, Fatih Türker, Rabia Yahyaoğlu Mamaç, Mustafa Yenigün. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics 2016; 71(4): 221 doi: 10.6061/clinics/2016(04)08
|
| 79 |
Yu‐Wen Pan, Meng‐Che Tsai, Yao‐Jong Yang, Ming‐Yin Chen, Shou‐Yen Chen, Yen‐Yin Chou. The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. The Kaohsiung Journal of Medical Sciences 2019; 35(12): 778 doi: 10.1002/kjm2.12118
|
| 80 |
Ana Maria Singeap, Laura Huiban. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 183 doi: 10.1007/978-3-031-33548-8_16
|
| 81 |
M. A. Livzan, O. V. Gaus, N. A. Nikolaev, T. S. Krolevetz. NAFLD: comorbidity and associated diseases. Experimental and Clinical Gastroenterology 2020; 1(10): 57 doi: 10.31146/1682-8658-ecg-170-10-57-65
|
| 82 |
Aikaterini Lavrentaki, Tom Thomas, Anuradhaa Subramanian, George Valsamakis, Neil Thomas, Konstantinos A. Toulis, Jingya Wang, Barbara Daly, Ponnusamy Saravanan, Dana Sumilo, George Mastorakos, Abd A. Tahrani, Krishnarajah Nirantharakumar. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. Journal of Diabetes and its Complications 2019; 33(10): 107401 doi: 10.1016/j.jdiacomp.2019.06.006
|
| 83 |
R. Leela-arporn, H. Ohta, N. Nagata, K. Sasaoka, M. Tamura, A. Dermlim, K. Nisa, K. Morishita, N. Sasaki, K. Nakamura, S. Takagi, K. Hosoya, M. Takiguchi. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study. The Veterinary Journal 2019; 248: 74 doi: 10.1016/j.tvjl.2019.04.011
|
| 84 |
Robert W. M. Min, Filbert W. M. Aung, Bryant Liu, Aliza Arya, Sanda Win. Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease. Biomedicines 2022; 10(8): 2035 doi: 10.3390/biomedicines10082035
|
| 85 |
Zeqi Guo, Miaomiao Li, Bing Han, Xingshun Qi. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis. Digestive and Liver Disease 2018; 50(11): 1153 doi: 10.1016/j.dld.2018.08.012
|
| 86 |
Donghee Kim, Won Kim, Sae Kyung Joo, Jeong Mo Bae, Jung Ho Kim, Aijaz Ahmed. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis. Clinical Gastroenterology and Hepatology 2018; 16(1): 123 doi: 10.1016/j.cgh.2017.08.014
|
| 87 |
|
| 88 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2021; : 157 doi: 10.1007/978-3-319-68729-2_6
|
| 89 |
So Yoon Choi, Dae Yong Yi, Soon Chul Kim, Ben Kang, Byung-Ho Choe, Yoon Lee, Yoo Min Lee, Eun Hye Lee, Hyo-Jeong Jang, You Jin Choi, Hyun Jin Kim. Severe Phenotype of Non-alcoholic Fatty Liver Disease in Pediatric Patients with Subclinical Hypothyroidism: a Retrospective Multicenter Study from Korea. Journal of Korean Medical Science 2021; 36(20) doi: 10.3346/jkms.2021.36.e137
|
| 90 |
Lynnda J. N. van Tienhoven‐Wind, Robin P. F. Dullaart. Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders. European Journal of Clinical Investigation 2015; 45(5): 494 doi: 10.1111/eci.12423
|
| 91 |
Miguel Malespin, Ammar Nassri. Endocrine Diseases and the Liver. Clinics in Liver Disease 2019; 23(2): 233 doi: 10.1016/j.cld.2018.12.006
|
| 92 |
A. O. Bueverov, P. O. Bogomolov, O. A. Nechayeva, A. V. Zilov. Cause-and-effect relationship between thyroid and liver diseases. Meditsinskiy sovet = Medical Council 2021; (15): 88 doi: 10.21518/2079-701X-2021-15-88-94
|
| 93 |
Peizhu Chen, Xuhong Hou, Li Wei, Liang Feng, Lichang Zhong, Lei Jiao, Hongmei Wang, Yuqian Bao, Weiping Jia. Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. European Journal of Clinical Investigation 2019; 49(4) doi: 10.1111/eci.13070
|
| 94 |
Sonal Sharma, Jonathan G. Stine, Thomas Verbeek, Dmitri Bezinover. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. Journal of Cardiothoracic and Vascular Anesthesia 2022; 36(8): 2616 doi: 10.1053/j.jvca.2021.07.020
|
| 95 |
Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi, Liang Xu. A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.862879
|
| 96 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Sahar Najafi Mobaraki, Sara Mavaddati, Soheil Hassanipour, Masood Sepehrimanesh. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 1591 doi: 10.1016/j.dsx.2019.03.009
|
| 97 |
Miroslava Nedyalkova, Ralitsa Robeva, Atanaska Elenkova, Vasil Simeonov. Chemometric exploratory data analysis for patients with diabetes type 2 and diabetic complications. Physical Sciences Reviews 2022; 7(7): 741 doi: 10.1515/psr-2020-0132
|